Sodium‐glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?Magdalena Kaczor, Dorota Wesół‐Kucharska, Milena Greczan et al.|JIMD Reports|2022Cited by 20
Early treatment of biotin–thiamine–responsive basal ganglia disease improves the prognosisDorota Wesół‐Kucharska, Dariusz Rokicki, Elżbieta Ciara et al.|Molecular Genetics and Metabolism Reports|2021Cited by 16
Clinical characteristics and long-term outcomes of patients with glycogen storage disease type 1b: a retrospective multi-center experience in PolandMagdalena Kaczor, Dariusz Rokicki, Dorota Wesół‐Kucharska et al.|Pediatric Endocrinology Diabetes and Metabolism|2022Cited by 13
Efficacy and Safety of Ketogenic Diet Treatment in Pediatric Patients with Mitochondrial DiseaseDorota Wesół‐Kucharska, Dariusz Rokicki, Milena Greczan et al.|Nutrients|2024Cited by 5
Improvement of cardiomyopathy after ketogenic diet in a patient with Leigh syndrome caused by MTND5 mutationDorota Wesół‐Kucharska, Dariusz Rokicki, Milena Greczan et al.|Research Square|2021Cited by 4